Porphysome nanotechnology: A paradigm shift in lipid-based supramolecular structures
暂无分享,去创建一个
[2] Mark Borden,et al. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. , 2007, Annual review of biomedical engineering.
[3] Raymond Bonnett,et al. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy , 1995 .
[4] H Stepp,et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.
[5] E. Tsuchida. Liposome‐Embedded Iron‐Porphyrins as an Artificial Oxygen Carrier , 1985, Annals of the New York Academy of Sciences.
[6] M. Dobrovolskaia,et al. Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.
[7] Chulhong Kim,et al. Porphyrin shell microbubbles with intrinsic ultrasound and photoacoustic properties. , 2012, Journal of the American Chemical Society.
[8] S. Shek,et al. Liposome‐Encapsulated 0.5% 5‐Aminolevulinic Acid with Intense Pulsed Light for the Treatment of Inflammatory Facial Acne: A Pilot Study , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[9] P. D. de Witte,et al. Liposomes for photodynamic therapy. , 2004, Advanced drug delivery reviews.
[10] Verteporfin Roundtable Participants. GUIDELINES FOR USING VERTEPORFIN (VISUDYNE®) IN PHOTODYNAMIC THERAPY TO TREAT CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES , 2002, Retina.
[11] K. Berg,et al. Porphyrin‐related photosensitizers for cancer imaging and therapeutic applications , 2005, Journal of microscopy.
[12] Xinmai Yang,et al. Photoacoustic tomography of a rat cerebral cortex in vivo with au nanocages as an optical contrast agent. , 2007, Nano letters.
[13] Roger Guilard,et al. The porphyrin handbook , 2002 .
[14] T. Lim,et al. Verteporfin PDT for non-standard indications—a review of current literature , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[15] H Stepp,et al. Fluorescence imaging and spectroscopy of 5-aminolevulinic acid induced protoporphyrin IX for the detection of neoplastic lesions in the oral cavity. , 1996, American journal of surgery.
[16] Gang Zheng,et al. Enzymatic regioselection for the synthesis and biodegradation of porphysome nanovesicles. , 2012, Angewandte Chemie.
[17] Mustafa Kurt,et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. , 2009, Journal of the American College of Cardiology.
[18] H. Bosmans,et al. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI , 2004, European Radiology.
[19] Manivannan Ethirajan,et al. The role of porphyrin chemistry in tumor imaging and photodynamic therapy. , 2011, Chemical Society reviews.
[20] E. Tsuchida,et al. Self-organized lipid-porphyrin bilayer membranes in vesicular form: nanostructure, photophysical properties, and dioxygen coordination. , 2002, Chemistry.
[21] R. Henkin,et al. Photodynamic therapy for intracranial neoplasms: investigations of photosensitizer uptake and distribution using indium-111 Photofrin-II single photon emission computed tomography scans in humans with intracranial neoplasms. , 1993, Neurosurgery.
[22] Vladimir P Torchilin,et al. Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. , 2002, International journal of pharmaceutics.
[23] Chulhong Kim,et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. , 2011, Nature materials.
[24] Z. Dai,et al. Conjugation of porphyrin to nanohybrid cerasomes for photodynamic diagnosis and therapy of cancer. , 2011, Angewandte Chemie.
[25] T. Hasan,et al. The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA). , 1995, Journal of photochemistry and photobiology. B, Biology.
[26] Gang Zheng,et al. Intrinsically copper-64-labeled organic nanoparticles as radiotracers. , 2012, Angewandte Chemie.
[27] P. Burns,et al. Microbubble-enhanced US in body imaging: what role? , 2010, Radiology.
[28] Lihong V. Wang,et al. Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain , 2004 .
[29] R. Fobel,et al. Optically controlled pore formation in self-sealing giant porphyrin vesicles. , 2014, Small.
[30] B. Wilson,et al. FRET quenching of photosensitizer singlet oxygen generation. , 2009, The journal of physical chemistry. B.
[31] J. Jang,et al. Multigram-scale fabrication of monodisperse conducting polymer and magnetic carbon nanoparticles. , 2005, Small.
[32] Jesse V. Jokerst,et al. Semiconducting Polymer Nanoparticles as Photoacoustic Molecular Imaging Probes in Living Mice , 2014, Nature nanotechnology.
[33] J. Christman,et al. Pivotal Role of Reactive Oxygen Species in Differential Regulation of Lipopolysaccharide-Induced Prostaglandins Production in Macrophages , 2013, Molecular Pharmacology.
[34] Zheng Huang,et al. A Review of Progress in Clinical Photodynamic Therapy , 2005, Technology in cancer research & treatment.
[35] B. Pogue,et al. Liposomal delivery of photosensitising agents , 2005, Expert opinion on drug delivery.
[36] J. West,et al. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. , 2007, Nano letters.
[37] V. Muzykantov,et al. Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities , 2012, Science.
[38] Prashant K. Jain,et al. Plasmonic photothermal therapy (PPTT) using gold nanoparticles , 2008, Lasers in Medical Science.
[39] Claudio H. Sibata,et al. Oncologic photodynamic therapy photosensitizers: a clinical review. , 2010, Photodiagnosis and photodynamic therapy.
[40] U. Schmidt-Erfurth,et al. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. , 2000, Survey of ophthalmology.
[41] Nanfeng Zheng,et al. Polypyrrole nanoparticles for high-performance in vivo near-infrared photothermal cancer therapy. , 2012, Chemical communications.
[42] Kai Yang,et al. In Vitro and In Vivo Near‐Infrared Photothermal Therapy of Cancer Using Polypyrrole Organic Nanoparticles , 2012, Advanced materials.
[43] S. Robledo,et al. Association of Acenaphthoporphyrins with Liposomes for the Photodynamic Treatment of Leishmaniasis , 2010, Photochemistry and photobiology.
[44] P. Bjerring,et al. Photodynamic therapy of acne vulgaris using 5‐aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.
[45] B. Wilson,et al. Biologically-Targeted Detection of Primary and Micro-Metastatic Ovarian Cancer , 2013, Theranostics.
[46] S. Chang,et al. 0.5% Liposome-encapsulated 5-aminolevulinic acid (ALA) photodynamic therapy for acne treatment , 2011, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.
[47] Kyung-Hwa Yoo,et al. Convertible organic nanoparticles for near-infrared photothermal ablation of cancer cells. , 2011, Angewandte Chemie.
[48] J. Ross,et al. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications , 1994, Cancer.
[49] S. H. Koenig,et al. Tissue distribution and stability of metalloporphyrin MRI contrast agents , 1987, Magnetic resonance in medicine.
[50] Changhui Li,et al. Biocompatible polypyrrole nanoparticles as a novel organic photoacoustic contrast agent for deep tissue imaging. , 2013, Nanoscale.
[51] G. Zheng,et al. Liposomal nanostructures for photosensitizer delivery , 2011, Lasers in surgery and medicine.
[52] Liyang Cui,et al. Targeting‐Triggered Porphysome Nanostructure Disruption for Activatable Photodynamic Therapy , 2014, Advanced healthcare materials.
[53] Nanfeng Zheng,et al. Correspondence on Amalgamation , 1973 .
[54] G. Mancini,et al. Efficient photoinactivation of methicillin-resistant Staphylococcus aureus by a novel porphyrin incorporated into a poly-cationic liposome. , 2007, The international journal of biochemistry & cell biology.
[55] Feng Gao,et al. In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. , 2010, ACS nano.
[56] Hyeonseok Yoon,et al. Kinetic study of the formation of polypyrrole nanoparticles in water-soluble polymer/metal cation systems: a light-scattering analysis. , 2010, Small.
[57] D. Phillips,et al. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.
[58] Kensuke Kurihara,et al. Self-reproduction of supramolecular giant vesicles combined with the amplification of encapsulated DNA. , 2011, Nature chemistry.
[59] M. Baptista,et al. Giant vesicles under oxidative stress induced by a membrane-anchored photosensitizer. , 2009, Biophysical Journal.
[60] Jonathan F. Lovell,et al. Ablation of Hypoxic Tumors with Dose-Equivalent Photothermal, but Not Photodynamic, Therapy Using a Nanostructured Porphyrin Assembly , 2013, ACS nano.
[61] Brian C. Wilson,et al. Inherently Multimodal Nanoparticle-Driven Tracking and Real-Time Delineation of Orthotopic Prostate Tumors and Micrometastases , 2013, ACS nano.
[62] Naomi J Halas,et al. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. , 2008, Accounts of chemical research.
[63] P. Cullis,et al. Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.
[64] Xiaohua Huang,et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. , 2006, Journal of the American Chemical Society.
[65] A. Jain,et al. LIPOSOMAL DELIVERY OF A PHOTOSENSITIZER, BENZOPORPHYRIN DERIVATIVE MONOACID RING A (BPD), TO TUMOR TISSUE IN A MOUSE TUMOR MODEL , 1993, Photochemistry and photobiology.
[66] Gang Zheng,et al. Self-assembled porphyrin nanodiscs with structure-dependent activation for phototherapy and photodiagnostic applications. , 2013, ACS nano.
[67] David Jaffray,et al. Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer , 2011, Theranostics.
[68] H Stepp,et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.